TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18421891

Group type: EXPERIMENTAL
Intervention: Group program focused on intensive training in techniques for eliciting the relaxation response (P1; n = 60)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Group program focused on healthy eating and physical activity (P2; n = 61)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Self-guided, mail-delivered version of P2 (P3; n = 101)
Number of subjects: 225
Study: 15848518

Group type: EXPERIMENTAL
Intervention: Mixed chimerism protocol with thymic transplantation of donor renal tissue, two donor-specific transfusions, low-intensity conditioning, and high-dose HSCT before renal transplantation.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group receiving standard immunosuppression (CyA and prednisolone) plus mycophenolate mofetil/azathioprine.
Number of subjects: 66
Study: 12209704

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 60 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 90 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 10340790

Group type: EXPERIMENTAL
Intervention: HLA‐DR2
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: HLA‐DR4
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: DR2‐positive and DR4‐negative genotypes
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: HLA‐DQB1*0302
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: DRB1*1501-positive, DRB1*0405-negative, and DQB1*0302-negative genotypes
Number of subjects: 93
Study: 8746886

Group type: EXPERIMENTAL
Intervention: New chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study: 1701714

Group type: EXPERIMENTAL
Intervention: Subcortical P300-like activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual stimulus presentation (digit 6 or 9)
Number of subjects: 0
Study: 6119042

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide 400 microgram per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide 200 microgram per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal budesonide (both dosages)
Number of subjects: 0
Study: 31800000

Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral therapy (ART)
Number of subjects: 4249

Group type: COMPARATOR
Intervention: Deferred antiretroviral therapy (ART)
Number of subjects: 4249
Study: 30239571

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR)
Number of subjects: 0
Study: 28400487

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 184
Study: 25822050

Group type: EXPERIMENTAL
Intervention: Individual interviews
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Focus groups
Number of subjects: 56
Study: 24165392

Group type: EXPERIMENTAL
Intervention: ADM-facilitated one-stage implant reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage tissue expander/implant (TE/I) reconstruction
Number of subjects: 0
Study: 21385158

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 19690943

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FICB) prophylaxis
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study: 17005549

Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eye drops twice daily for 2 days
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eye drops twice daily for 3 days
Number of subjects: 670

Group type: COMPARATOR
Intervention: Azithromycin single 20 mg/kg oral dose
Number of subjects: 670

Group type: EXPERIMENTAL
Intervention: All groups (eye drops and oral)
Number of subjects: 670
Study: 15089820

Group type: EXPERIMENTAL
Intervention: Intravenous tyramine injections
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11564358

Group type: EXPERIMENTAL
Intervention: Telehomecare intervention
Number of subjects: 0
Study: 11001599

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitor therapy (donepezil)
Number of subjects: 30
Study: 9104896

Group type: EXPERIMENTAL
Intervention: Aspirin treatment at hospital admission
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Calcium antagonists treatment at hospital admission
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Beta blockers treatment at hospital admission
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Combination anti-ischemic therapy at hospital admission
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Nitrates treatment at discharge
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Combination anti-ischemic therapy at discharge
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors treatment
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Lipid-lowering agents treatment
Number of subjects: 1286
Study: 1487611

Group type: EXPERIMENTAL
Intervention: Distal spleno-renal shunt (DSRS)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Distal spleno-renal shunt (DSRS) in non-alcoholic patients
Number of subjects: 4

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy (EVS)
Number of subjects: 4
Study: 2881819

Group type: EXPERIMENTAL
Intervention: IPV + pertussis
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: IPV + DP
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: IPV + DTP
Number of subjects: 4

Group type: COMPARATOR
Intervention: IPV alone
Number of subjects: 4
Study: 29660351

Group type: EXPERIMENTAL
Intervention: Betrixaban
Number of subjects: 7513

Group type: COMPARATOR
Intervention: Standard-of-care enoxaparin
Number of subjects: 7513

Group type: EXPERIMENTAL
Intervention: Low hemoglobin (categorical or continuous)
Number of subjects: 7513

Group type: EXPERIMENTAL
Intervention: Low hemoglobin
Number of subjects: 7513
Study: 27067394

Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Sonidegib 800 mg
Number of subjects: 94
Study: 24814043

Group type: EXPERIMENTAL
Intervention: Two 4-hour interactive training sessions for nursing staff on appropriate medication treatment
Number of subjects: 227

Group type: COMPARATOR
Intervention: Routine care without additional training (control group)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Two 4-hour interactive training sessions for nursing staff
Number of subjects: 227
Study: 23136158

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 385

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 385
Study: 19606374

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Obese children
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Adiponectin associations
Number of subjects: 82
Study: 18606286

Group type: EXPERIMENTAL
Intervention: Adaptation Test (novice drivers)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Adaptation Test (unsafe drivers and overconfident drivers)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Adaptation Test (experienced drivers)
Number of subjects: 434
Study: 15723732

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 1403

Group type: EXPERIMENTAL
Intervention: Active 4-mg nicotine lozenge
Number of subjects: 1403

Group type: COMPARATOR
Intervention: Placebo (patch)
Number of subjects: 1403

Group type: COMPARATOR
Intervention: Placebo (lozenge)
Number of subjects: 1403
Study: 11952054

Group type: EXPERIMENTAL
Intervention: Bright Light-Caffeine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bright Light-Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dim Light-Caffeine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Dim Light-Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bright Light (3000 lx)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg)
Number of subjects: 11
Study: 10069753

Group type: EXPERIMENTAL
Intervention: Inconsistent responses from male adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inconsistent responses from Black and Hispanic adolescents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Living status and academic achievements
Number of subjects: 0
Study: 7717837

Group type: EXPERIMENTAL
Intervention: Neoprene chest belt
Number of subjects: 16

Group type: COMPARATOR
Intervention: Webbing thigh belt
Number of subjects: 16

Group type: COMPARATOR
Intervention: No belt
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Neoprene chest belt (lower thoracic paraplegia)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Neoprene chest belt (able-bodied controls)
Number of subjects: 16
Study: 1903907

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 66

Group type: COMPARATOR
Intervention: No ultrasound
Number of subjects: 66
Study: 31986290

Group type: EXPERIMENTAL
Intervention: Potassium-enriched salt substitute
Number of subjects: 20996

Group type: COMPARATOR
Intervention: Usual salt
Number of subjects: 20996

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 20996
Study: 29985566

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (O3FA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 25694257

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (group 1, n = 197)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Intra-cervical Foley catheter plus vaginal isosorbide mononitrate (group 2, n = 198)
Number of subjects: 395
Study: 25193793

Group type: EXPERIMENTAL
Intervention: Test meal rich in LC n‐3 PUFA
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control meal (low in LC n‐3 PUFA and polyphenols)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Test meal rich in polyphenols and low in LC n‐3 PUFA
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Test meal rich in both LC n‐3 PUFA and polyphenols
Number of subjects: 78
Study: 22525651

Group type: EXPERIMENTAL
Intervention: Local cold application (ice applied intermittently to one leg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control leg (no cold application)
Number of subjects: 11
Study: 19822328

Group type: EXPERIMENTAL
Intervention: PWP condition (picture-word-picture)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: PWW condition (picture-word-word)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Noninterference control condition (P-W)
Number of subjects: 2
Study: 18774895

Group type: EXPERIMENTAL
Intervention: Culturally proficient weight loss and weight loss maintenance program for black women (6-month weight loss program followed by a 1-year maintenance program)
Number of subjects: 213

Group type: COMPARATOR
Intervention: General health control group
Number of subjects: 213
Study: 16025971

Group type: EXPERIMENTAL
Intervention: Combined internal-external therapy of TCM (internal administering of Chinese recipe and external applying of Fuxiong plaster)
Number of subjects: 817

Group type: COMPARATOR
Intervention: Simulative placeboes (control group)
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Combined internal-external therapy of TCM
Number of subjects: 817
Study: 12844132

Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg daily, 400 mg on day 1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11111141

Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily at 4, 8 and 16 micromol/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N(G)‐monomethyl‐L‐arginine (LNMMA) infused intracoronarily
Number of subjects: 0
Study: 8806006

Group type: EXPERIMENTAL
Intervention: Intranasal salmon calcitonin (50 IU per dose)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (excipient only)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (salmon calcitonin and placebo)
Number of subjects: 120
Study: 1282615

Group type: EXPERIMENTAL
Intervention: Nisoldipine at a dose of 20 mg daily for 4 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Beta-acetyldigoxin at a dose of 0.3 mg daily for 4 weeks
Number of subjects: 32
Study: 6360334

Group type: EXPERIMENTAL
Intervention: Intracavity irradiation
Number of subjects: 105

Group type: COMPARATOR
Intervention: External beam irradiation
Number of subjects: 105
Study: 31016819

Group type: EXPERIMENTAL
Intervention: Internal podalic version
Number of subjects: 150

Group type: COMPARATOR
Intervention: Short curved forceps
Number of subjects: 150

Group type: COMPARATOR
Intervention: Vacuum
Number of subjects: 150
Study: 29138241

Group type: EXPERIMENTAL
Intervention: GH (2 mg/day)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined GH (2 mg/day) and testosterone (250 mg/week)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Testosterone (250 mg/week)
Number of subjects: 96
Study: 27079660

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR) 3,000 mg/day orally for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24394686

Group type: EXPERIMENTAL
Intervention: Xylitol syrup (5 g, 3 times per day)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 22440372

Group type: EXPERIMENTAL
Intervention: Sevoflurane Cristália®
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sevoflurane Abbott®
Number of subjects: 130
Study: 19616743

Group type: EXPERIMENTAL
Intervention: High-dose radiotherapy (HDRT)
Number of subjects: 2812

Group type: COMPARATOR
Intervention: Conventional-dose radiotherapy (CDRT)
Number of subjects: 2812
Study: 17372833

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 17
Study: 16376748

Group type: EXPERIMENTAL
Intervention: Coronary flow reserve (CFR) measurement determined by TTE
Number of subjects: 51

Group type: COMPARATOR
Intervention: Dobutamine stress echocardiography (DSE)
Number of subjects: 51
Study: 12212692

Group type: EXPERIMENTAL
Intervention: Postoperative NSVT patients
Number of subjects: 228

Group type: COMPARATOR
Intervention: Nonpostoperative NSVT patients
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Postoperative NSVT identified early (<10 days)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Postoperative NSVT identified late (10-30 days)
Number of subjects: 228
Study: 9796348

Group type: EXPERIMENTAL
Intervention: Health promotion behavior
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Social activities participation
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Medical examinations frequency
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Motivation for health promotion
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Desire to enjoy activities
Number of subjects: 397
Study: 8719263

Group type: EXPERIMENTAL
Intervention: Metoprolol (0.29 mg kg‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Propranolol (0.28 mg kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Head-up tilt
Number of subjects: 8
Study: 2136577

Group type: EXPERIMENTAL
Intervention: Vibration trials (2.5 seconds application of a vibrator to the maternal abdomen)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No-stimulus control trials
Number of subjects: 36
Study: 773081

Group type: EXPERIMENTAL
Intervention: Inderal 40 mg q.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: d-propranolol 40 mg q.i.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Inderal
Number of subjects: 20
Study: 30201446

Group type: EXPERIMENTAL
Intervention: Training attachment behaviors to pregnant women (6 sessions of 90-min classes)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 190
Study: 28224720

Group type: EXPERIMENTAL
Intervention: Pyridostigmine bromide (3 × 60 mg/day for 14 days)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fludrocortisone (1 × 0.2 mg/day for 14 days)
Number of subjects: 13
Study: 26429126

Group type: EXPERIMENTAL
Intervention: Semi-compliant balloon
Number of subjects: 50

Group type: COMPARATOR
Intervention: Other types of balloons
Number of subjects: 50
Study: 22782640

Group type: EXPERIMENTAL
Intervention: Golimumab with isoniazid for latent TB treatment
Number of subjects: 2210

Group type: EXPERIMENTAL
Intervention: Golimumab without isoniazid
Number of subjects: 2210

Group type: COMPARATOR
Intervention: Placebo and golimumab groups
Number of subjects: 2210
Study: 22087637

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fenofibrate (FENO)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ezetimibe plus Fenofibrate (EZE+FENO)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin plus Fenofibrate (EZE/SIMVA+FENO)
Number of subjects: 100
Study: 19221912

Group type: EXPERIMENTAL
Intervention: Motivational interviewing with a novice therapist in addition to treatment as usual (n=22)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Treatment as usual alone (n=25)
Number of subjects: 47
Study: 16323128

Group type: EXPERIMENTAL
Intervention: 0.5% PRO 2000 gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study: 12204862

Group type: EXPERIMENTAL
Intervention: Breathing room air during symptom-limited maximum cycle exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyperoxic breathing at rest
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 20
Study: 11279973

Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo pulsing electromagnetic fields
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields (additional exposure)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Actual pulsing electromagnetic fields (no additional exposure)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo group (after additional exposure)
Number of subjects: 42
Study: 8727016

Group type: EXPERIMENTAL
Intervention: Malleoloc ankle joint orthosis
Number of subjects: 12
Study: 1764954

Group type: EXPERIMENTAL
Intervention: Budesonide 400 micrograms once-daily
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Budesonide 200 micrograms twice-daily
Number of subjects: 342

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 342
Study: 6859504

Group type: EXPERIMENTAL
Intervention: 2% lignocaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 2% lignocaine + morphine sulphate 4 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: normal saline + morphine sulphate 4 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 70
Study: 30816729

Group type: EXPERIMENTAL
Intervention: Dual perspective message (false balance condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provaccine messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to online comments questioning HPV vaccination
Number of subjects: 0
Study: 27591991

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg/day from day 1 for five consecutive days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Palonosetron and dexamethasone in approved therapeutic dose from day 1 of chemotherapy
Number of subjects: 100
Study: 26216550

Group type: EXPERIMENTAL
Intervention: LED phototherapy applied to one side of the dental arch
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control side (no LED phototherapy)
Number of subjects: 11
Study: 24368354

Group type: EXPERIMENTAL
Intervention: LTTE performed (LTTEp)
Number of subjects: 215

Group type: COMPARATOR
Intervention: non-LTTE
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: LTTE performed (LTTEp) in traumatic brain injury patients
Number of subjects: 215

Group type: COMPARATOR
Intervention: non-LTTE in traumatic brain injury patients
Number of subjects: 215
Study: 22649526

Group type: EXPERIMENTAL
Intervention: Guided internet-delivered cognitive behavior therapy (ICBT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Moderated online discussion forum only (control)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Therapist experience (experienced vs inexperienced)
Number of subjects: 204
Study: 19687128

Group type: EXPERIMENTAL
Intervention: standard treatment plus applied behavioral analysis (N=32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: standard treatment only (N=31)
Number of subjects: 63
Study: 17300303

Group type: EXPERIMENTAL
Intervention: 200 ml of 20% human albumin solution administered over 120 seconds
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 30 mg of furosemide intravenously along with albumin
Number of subjects: 28
Study: 15067419

Group type: EXPERIMENTAL
Intervention: Lavasept (polyhexamethylenbiguanid) 1.25%
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: PVP-iodine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ringer's solution
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lavasept
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All solutions tested
Number of subjects: 29
Study: 11199951

Group type: EXPERIMENTAL
Intervention: Naltrexone with cognitive behavioral therapy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo with cognitive behavioral therapy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 131
Study: 9894384

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional beta-blockers
Number of subjects: 0
Study: 8538382

Group type: EXPERIMENTAL
Intervention: Formula supplemented with 0.36% DHA (fish oil and evening primrose oil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breast feeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formula supplemented with FO+EPO
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breast feeding and placebo formula
Number of subjects: 0
Study: 2806133

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 108

Group type: COMPARATOR
Intervention: Injection Sclerotherapy
Number of subjects: 108